Upregulated GPCRs that have been proposed as therapeutic targets in cancer included the adenosine receptors ADORA1 and ADORA3, and important GPCRs for autocrine growth factors in cancer, such as bombesin receptor NMBR, and neurotensin receptor NTSR145,46. The gene discussed is ADORA3; the disease is cancer.